PHORA-USE Registry (PHORAR)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07942012. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pulmonary Hypertension Outcomes Risk Assessment Registry
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pulmonary arterial hypertension (PAH) is a rare and progressive disease associated with significant illness and reduced survival. The PHORA-USE Registry (PHORAR) is a prospective, multicenter observational registry designed to collect real-world clinical data from adult and pediatric patients with PAH receiving routine clinical care. The purpose of this registry is to create a centralized database that can be used to better understand patient characteristics, treatment patterns, disease progression, and clinical outcomes. Information collected through the registry will support observational analyses aimed at identifying factors associated with outcomes and may contribute to the development of improved risk assessment and treatment strategies for patients with PAH.
Study identification
- NCT ID
- NCT07942012
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 650 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Day and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2027 (Estimated)
- Primary completion
- Jan 2031 (Estimated)
- Completion
- Jan 2031 (Estimated)
- Last update posted
- Nov 17, 2026
2027 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sentara Pulmonary Arterial Hypertension Clinic | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07942012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2026 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.